ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Douglas Lane & Associates, LLC | 11,000 | $8,580 | 0.00% |
| OSAIC HOLDINGS, INC. | 10,458 | $8,157 | 0.00% |
| FMR LLC | 1,733,141 | $1,351,850 | 0.00% |
| US BANCORP \DE\ | 1,058 | $825 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,697,125 | $3,663,758 | 0.00% |
| STIFEL FINANCIAL CORP | 29,833 | $23,270 | 0.00% |
| WELLS FARGO & COMPANY/MN | 54,745 | $42,701 | 0.00% |
| NORTHERN TRUST CORP | 57,423 | $44,790 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 4,353 | $3 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 117,909 | $91,969 | 0.00% |
| STATE STREET CORP | 299,101 | $233,299 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 300,061 | $234,048 | 0.00% |
| Janney Montgomery Scott LLC | 30,000 | $23 | 0.00% |
| CITIGROUP INC | 582,275 | $454,175 | 0.00% |
| HSBC HOLDINGS PLC | 26,064 | $20,069 | 0.00% |
| GOLDMAN SACHS GROUP INC | 57,611 | $44,937 | 0.00% |
| MORGAN STANLEY | 2,051,346 | $1,600,050 | 0.00% |
| Invesco Ltd. | 45,906 | $35,807 | 0.00% |
External links
This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q3 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.